The Oncology Institute (TOI)
(Delayed Data from NSDQ)
$0.67 USD
-0.01 (-1.58%)
Updated May 16, 2024 04:00 PM ET
After-Market: $0.65 -0.02 (-3.45%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | -83.33% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.36 |
Next Year | -0.17 |
EPS (TTM) | -0.81 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 102.46M | 107.06M | 412.53M | 482.79M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 102.46M | 107.06M | 412.53M | 482.79M |
Low Estimate | 102.46M | 107.06M | 412.53M | 482.79M |
Year ago Sales | 80.22M | 82.04M | 324.24M | 412.53M |
Year over Year Growth Est. | 27.72% | 30.50% | 27.23% | 17.03% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.07 | -0.36 | -0.17 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.09 | -0.07 | -0.36 | -0.17 |
Low Estimate | -0.09 | -0.07 | -0.36 | -0.17 |
Year ago EPS | -0.19 | -0.19 | -0.69 | -0.36 |
Year over Year Growth Est. | 52.63% | 63.16% | 47.83% | 52.78% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.07 | -0.36 | -0.17 |
7 Days Ago | -0.09 | -0.07 | -0.36 | -0.17 |
30 Days Ago | -0.09 | -0.07 | -0.36 | -0.17 |
60 Days Ago | NA | NA | -0.39 | -0.19 |
90 Days Ago | NA | NA | -0.41 | -0.22 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.09 | -0.07 | -0.36 | -0.17 |
Zacks Consensus Estimate | -0.09 | -0.07 | -0.36 | -0.17 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.21 | -0.19 | -0.19 | NA |
Estimate | -0.12 | -0.11 | -0.13 | -0.17 | NA |
Difference | -0.10 | -0.10 | -0.06 | -0.02 | -0.07 |
Surprise | -83.33% | -90.91% | -46.15% | -11.76% | -58.04% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more